Advances in translational medicine for the management of melanoma: A narrative review
Avances en medicina traslacional para el manejo del melanoma: Una revisión narrativa
Abstract
Introduction: Melanoma is a highly immunogenic neoplasm whose treatment has evolved with the development of innovative immunotherapeutic strategies. Objective: To analyze advances in immunotherapy and translational medicine for the treatment of melanoma, highlighting new therapies and their impact on clinical practice. Methodology: A narrative review was carried out in scientific databases, including Medline, PubMed, EMBASE, Cochrane Library, OVID and ClinicalKey. Articles were taken in English and Spanish, without time restriction. Relevant studies on immunotherapy, cell therapy, oncolytic viruses and personalized vaccines were selected. Results: The combination of immune checkpoint inhibitors with emerging therapies has improved tumor response and survival. However, tumor heterogeneity and immunosuppression of the microenvironment remain challenges. Conclusion: Translational medicine is key to optimizing melanoma treatment. Interdisciplinary research and biomarker development will allow more effective and personalized therapies, improving clinical outcomes in this pathology. Keywords: Melanoma; Neoplasms; Nevi and Melanomas; Skin Neoplasms; Neuroendocrine Tumors; Therapeutics; Translational Science, Biomedical (Source: MeSH, NLM).
Downloads
Published
2025-07-26
How to Cite
Arenas-Sánchez, K. A., Perdomo-Farelo, L. D., Tovar-Mera, A., Gómez-Gallego, A. M., Vieira-Rios, S. M., Solarte-Encarnación, A., & Serna-Trejos, J. S. (2025). Advances in translational medicine for the management of melanoma: A narrative review: Avances en medicina traslacional para el manejo del melanoma: Una revisión narrativa. Peruvian Journal of Health Care and Global Health, 9(2). Retrieved from http://revista.uch.edu.pe/index.php/hgh/article/view/337
Issue
Section
Reviews
License
Copyright (c) 2025 Kelly Andrea Arenas-Sánchez, Luis David Perdomo-Farelo, Andrea Tovar-Mera, Ana María Gómez-Gallego, Sara María Vieira-Rios, Angelly Solarte-Encarnación, Juan Santiago Serna-Trejos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The authors will retain their copyright and will guarantee to the journal right of first publication of their work, which will simultaneously be under a Creative Commons Attribution 4.0 License that allows third parties to share the work whenever attribuying their author and first publication in this journal.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post online a pre-publication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
